During the past decade, Shenzhen University General Hospital conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shenzhen University General Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Shenzhen University General Hospital" with 3 trials sponsored, "Chinese PLA General Hospital" with 2 trials sponsored, "Incyte Corporation" with 2 trials sponsored and "Shenzhen People's Hospital" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shenzhen University General Hospital" #1 collaborator was "Shenzhen University General Hospital" with 2 trials as a collaborator, "Anhui Provincial Hospital" with 1 trials as a collaborator, "First Affiliated Hospital Xi'an Jiaotong University" with 1 trials as a collaborator, "Shaanxi Provincial People's Hospital" with 1 trials as a collaborator and "Shanghai 10th People's Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Shenzhen University General Hospital" are "Dual-target CAR-T Cells" (2 trials), "Myelofibrosis" (2 trials), "Pertussis" (2 trials), "Post Essential Thrombocythemia Myelofibrosis" (2 trials) and "Post Polycythemia Vera Myelofibrosis" (2 trials). Many other conditions were trialed in "Shenzhen University General Hospital" in a lesser frequency.

Most popular intervention types in "Shenzhen University General Hospital" are "Drug" (11 trials), "Biological" (5 trials), "Procedure" (3 trials), "Combination Product" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Blood sample" (2 trials), "CD19 CART" (2 trials), "Data collection" (2 trials), "Erdafitinib" (2 trials) and "Lazertinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Shenzhen University General Hospital" are 18 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Shenzhen University General Hospital". 2 are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Shenzhen University General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Shenzhen University General Hospital, 6 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Shenzhen University General Hospital has several departments that took part in Clinical trials: "Department of Nephrology,1st Affiliated Hospital,Shenzhen University" - 2 trials, "Institution of Hepatobiliary Surgery, Southwest Hospital" - 2 trials